BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 15584988)

  • 1. Recovery and life span of 111indium-radiolabeled platelets treated with pathogen inactivation with amotosalen HCl (S-59) and ultraviolet A light.
    Snyder E; Raife T; Lin L; Cimino G; Metzel P; Rheinschmidt M; Baril L; Davis K; Buchholz DH; Corash L; Conlan MG
    Transfusion; 2004 Dec; 44(12):1732-40. PubMed ID: 15584988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogen inactivation of platelets with a photochemical treatment with amotosalen HCl and ultraviolet light: process used in the SPRINT trial.
    Pineda A; McCullough J; Benjamin RJ; Cable R; Strauss RG; Burgstaler E; Porter S; Lin L; Metzel P; Conlan MG;
    Transfusion; 2006 Apr; 46(4):562-71. PubMed ID: 16584432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelets photochemically treated with amotosalen HCl and ultraviolet A light correct prolonged bleeding times in patients with thrombocytopenia.
    Slichter SJ; Raife TJ; Davis K; Rheinschmidt M; Buchholz DH; Corash L; Conlan MG
    Transfusion; 2006 May; 46(5):731-40. PubMed ID: 16686840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amotosalen interactions with platelet and plasma components: absence of neoantigen formation after photochemical treatment.
    Lin L; Conlan MG; Tessman J; Cimino G; Porter S
    Transfusion; 2005 Oct; 45(10):1610-20. PubMed ID: 16181212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementation of the INTERCEPT Blood System for Platelets into routine blood bank manufacturing procedures: evaluation of apheresis platelets.
    Janetzko K; Lin L; Eichler H; Mayaudon V; Flament J; Klüter H
    Vox Sang; 2004 May; 86(4):239-45. PubMed ID: 15144528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leukoreduced buffy coat-derived platelet concentrates photochemically treated with amotosalen HCl and ultraviolet A light stored up to 7 days: assessment of hemostatic function under flow conditions.
    Lozano M; Galan A; Mazzara R; Corash L; Escolar G
    Transfusion; 2007 Apr; 47(4):666-71. PubMed ID: 17381625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the psoralen-based photochemical pathogen inactivation on mitochondrial DNA in platelets.
    Bruchmüller I; Lösel R; Bugert P; Corash L; Lin L; Klüter H; Janetzko K
    Platelets; 2005 Dec; 16(8):441-5. PubMed ID: 16287610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical safety of platelets photochemically treated with amotosalen HCl and ultraviolet A light for pathogen inactivation: the SPRINT trial.
    Snyder E; McCullough J; Slichter SJ; Strauss RG; Lopez-Plaza I; Lin JS; Corash L; Conlan MG;
    Transfusion; 2005 Dec; 45(12):1864-75. PubMed ID: 16371039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of in vitro storage properties of prestorage pooled whole blood-derived platelets suspended in 100 percent plasma and treated with amotosalen and long-wavelength ultraviolet light.
    Wagner SJ; Skripchenko A; Myrup A; Awatefe H; Thompson-Montgomery D; Moroff G; Carmichael P; Lin L
    Transfusion; 2009 Apr; 49(4):704-10. PubMed ID: 19171001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photochemical treatment of platelet concentrates with amotosalen hydrochloride and ultraviolet A light inactivates free and latent cytomegalovirus in a murine transfusion model.
    Jordan CT; Saakadze N; Newman JL; Lezhava LJ; Maiers TT; Hillyer WM; Roback JD; Hillyer CD
    Transfusion; 2004 Aug; 44(8):1159-65. PubMed ID: 15265119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymerase chain reaction inhibition assay documenting the amotosalen-based photochemical pathogen inactivation process of platelet concentrates.
    Bruchmüller I; Janetzko K; Bugert P; Mayaudon V; Corash L; Lin L; Klüter H
    Transfusion; 2005 Sep; 45(9):1464-72. PubMed ID: 16131379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inactivation of parvovirus B19 in human platelet concentrates by treatment with amotosalen and ultraviolet A illumination.
    Sawyer L; Hanson D; Castro G; Luckett W; Dubensky TW; Stassinopoulos A
    Transfusion; 2007 Jun; 47(6):1062-70. PubMed ID: 17524098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Photochemical inactivation with amotosalen and long-wavelength ultraviolet light of Plasmodium and Babesia in platelet and plasma components.
    Grellier P; Benach J; Labaied M; Charneau S; Gil H; Monsalve G; Alfonso R; Sawyer L; Lin L; Steiert M; Dupuis K
    Transfusion; 2008 Aug; 48(8):1676-84. PubMed ID: 18503613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photochemical treatment of plasma with amotosalen and UVA light: process validation in three European blood centers.
    Schlenke P; Hervig T; Isola H; Wiesel ML; Kientz D; Pinkoski L; Singh Y; Lin L; Corash L; Cazenave JP
    Transfusion; 2008 Apr; 48(4):697-705. PubMed ID: 18194378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transfusion of 7-day-old amotosalen photochemically treated buffy-coat platelets to patients with thrombocytopenia: a pilot study.
    Simonsen AC; Johansson PI; Conlan MG; Jacquet M; Lin JS; Junge K; Lin L; Sørensen H; Borregaard N; Flament J
    Transfusion; 2006 Mar; 46(3):424-33. PubMed ID: 16533286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pathogen reduction treatment of platelets with S-59 HCl (Amotosalen) plus ultraviolet A light: genotoxicity profile and hazard assessment.
    Tice RR; Gatehouse D; Kirkland D; Speit G
    Mutat Res; 2007 Jun; 630(1-2):50-68. PubMed ID: 17433761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fresh frozen plasma prepared with amotosalen HCl (S-59) photochemical pathogen inactivation: transfusion of patients with congenital coagulation factor deficiencies.
    de Alarcon P; Benjamin R; Dugdale M; Kessler C; Shopnick R; Smith P; Abshire T; Hambleton J; Matthew P; Ortiz I; Cohen A; Konkle BA; Streiff M; Lee M; Wages D; Corash L
    Transfusion; 2005 Aug; 45(8):1362-72. PubMed ID: 16078927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of safety in neonates for transfusion of platelets and plasma prepared with amotosalen photochemical pathogen inactivation treatment by a 1-month intravenous toxicity study in neonatal rats.
    Ciaravino V; Hanover J; Lin L; Sullivan T; Corash L
    Transfusion; 2009 May; 49(5):985-94. PubMed ID: 19175545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An active haemovigilance programme characterizing the safety profile of 7437 platelet transfusions prepared with amotosalen photochemical treatment.
    Osselaer JC; Cazenave JP; Lambermont M; Garraud O; Hidajat M; Barbolla L; Tardivel R; Defoin L; Waller C; Mendel I; Raidot JP; Kandel G; De Meuter R; Fabrigli P; Dehenau D; Arroyo JL; Padrón F; Gouezec H; Corral M; Jacquet M; Sundin D; Lin L; Corash L
    Vox Sang; 2008 May; 94(4):315-23. PubMed ID: 18248574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photochemical treatment of platelet concentrates with amotosalen and long-wavelength ultraviolet light inactivates a broad spectrum of pathogenic bacteria.
    Lin L; Dikeman R; Molini B; Lukehart SA; Lane R; Dupuis K; Metzel P; Corash L
    Transfusion; 2004 Oct; 44(10):1496-504. PubMed ID: 15383024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.